Harrow, Inc. (HROW) stock
HROWNasdaqPharmaceutical PreparationsFiscal year ends December 31
$30.12+1.82 (+6.43%)
Close on Nov 13, 2026Market cap $1.13BP/E –Yield –
Harrow total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Harrow's total debt was $292.72M at Sep 30, 2026. For fiscal 2025 it was $243.18M, up 10.8% from the year before. Over ten years it grew 40.1% a year on average. The highest annual figure on record is $243.18M in fiscal 2025.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $243.18M | +10.8% |
| FY2024 | Dec 31, 2024 | $219.54M | +18.1% |
| FY2023 | Dec 31, 2023 | $185.89M | +78.4% |
| FY2022 | Dec 31, 2022 | $104.17M | +45.4% |
| FY2021 | Dec 31, 2021 | $71.65M | +478.9% |
| FY2020 | Dec 31, 2020 | $12.38M | +1.3% |
| FY2019 | Dec 31, 2019 | $12.22M | -3.9% |
| FY2018 | Dec 31, 2018 | $12.72M | -9.2% |
| FY2017 | Dec 31, 2017 | $14.01M | +76.5% |
| FY2016 | Dec 31, 2016 | $7.94M | -4.8% |
| FY2015 | Dec 31, 2015 | $8.34M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $292.72M | +20.5% |
| Q2 FY2026 | Jun 30, 2026 | $292.38M | +659.7% |
| Q1 FY2026 | Mar 31, 2026 | $292.09M | +159.6% |
| Q4 FY2025 | Dec 31, 2025 | $243.18M | +10.8% |
| Q3 FY2025 | Sep 30, 2025 | $242.87M | +30.5% |
| Q2 FY2025 | Jun 30, 2025 | $38.48M | -79.2% |
| Q1 FY2025 | Mar 31, 2025 | $112.50M | -38.9% |
| Q4 FY2024 | Dec 31, 2024 | $219.54M | +18.1% |
| Q3 FY2024 | Sep 30, 2024 | $186.06M | +2.1% |
| Q2 FY2024 | Jun 30, 2024 | $185.02M | +9.0% |
| Q1 FY2024 | Mar 31, 2024 | $184.15M | +9.1% |
| Q4 FY2023 | Dec 31, 2023 | $185.89M | +78.4% |
| Q3 FY2023 | Sep 30, 2023 | $182.19M | +152.2% |
| Q2 FY2023 | Jun 30, 2023 | $169.71M | +135.6% |
| Q1 FY2023 | Mar 31, 2023 | $168.85M | +135.0% |
| Q4 FY2022 | Dec 31, 2022 | $104.17M | +45.4% |
| Q3 FY2022 | Sep 30, 2022 | $72.24M | +1.1% |
| Q2 FY2022 | Jun 30, 2022 | $72.04M | +1.1% |
| Q1 FY2022 | Mar 31, 2022 | $71.85M | +553.4% |
| Q4 FY2021 | Dec 31, 2021 | $71.65M | +478.9% |
| Q3 FY2021 | Sep 30, 2021 | $71.46M | +479.5% |
| Q2 FY2021 | Jun 30, 2021 | $71.27M | +448.7% |
| Q1 FY2021 | Mar 31, 2021 | $11.00M | -5.2% |
| Q4 FY2020 | Dec 31, 2020 | $12.38M | +1.3% |
| Q3 FY2020 | Sep 30, 2020 | $12.33M | -4.2% |
| Q2 FY2020 | Jun 30, 2020 | $12.99M | -3.8% |
| Q1 FY2020 | Mar 31, 2020 | $11.61M | -2.5% |
| Q4 FY2019 | Dec 31, 2019 | $12.22M | -3.9% |
| Q3 FY2019 | Sep 30, 2019 | $12.87M | +1.6% |
| Q2 FY2019 | Jun 30, 2019 | $13.50M | +1.7% |
| Q1 FY2019 | Mar 31, 2019 | $11.90M | -14.1% |
| Q4 FY2018 | Dec 31, 2018 | $12.72M | -9.2% |
| Q3 FY2018 | Sep 30, 2018 | $12.67M | -8.7% |
| Q2 FY2018 | Jun 30, 2018 | $13.27M | +12.0% |
| Q1 FY2018 | Mar 31, 2018 | $13.87M | +130.7% |
| Q4 FY2017 | Dec 31, 2017 | $14.01M | +76.5% |
| Q3 FY2017 | Sep 30, 2017 | $13.88M | – |
| Q2 FY2017 | Jun 30, 2017 | $11.85M | – |
| Q1 FY2017 | Mar 31, 2017 | $6.01M | – |
| Q4 FY2016 | Dec 31, 2016 | $7.94M | – |
See a number that looks wrong?